Clinical Safety

Phase I clinical trials are currently evaluating the safety and efficacy of BI 1703880 in human patients with advanced solid tumors following successful preclinical validations. This breakthrough comes at a pivotal moment in oncology, as researchers strive to solve the disconnect between localized

Researchers at Mass General Brigham and the University of Chicago have demonstrated that it is possible to decouple therapeutic power from systemic toxicity in cellular immunotherapy. This clinical development addresses the long-standing challenge of multiple myeloma, a hematologic cancer that

A primary mission for the PSRM involves dismantling the 'magic bullet' myth by clarifying that regenerative medicine is a multifaceted field focused on long-term biological restoration. The Philippine Society of Regenerative Medicine (PSRM) was established at a pivotal moment in the nation's

The perceived efficiency of telehealth on a spreadsheet frequently masks the invisible labor required to manage medication loops from a distance. For facilities like St. Vincent’s Hospital in Sydney, Australia, the transition to digital pharmaceutical services was not merely a technological upgrade

Traditional diagnostic methods for middle ear disorders have historically forced surgeons to rely on audiometric patterns and invasive exploratory tympanotomy procedures. This necessity often placed patients in a precarious position, as the precise nature of their hearing deficit remained unknown

Standard immunotherapy often fails when cancer cells stop expressing a single target protein, a biological loophole that the new trispecific design aims to close by targeting CD19, CD20, and CD22. This experimental breakthrough, emerging from a phase I clinical trial at The Ohio State University